Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (331-340 of 373) with videos related to

Pageof 38
Sort By:
The New England Journal of Medicine|January 25, 2013
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysisIain C Macdougall, Robert Provenzano, Amit Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitorsGavin Whitehouse, Elizabeth Gray, Sotiris Mastoridis, et al.
European Journal of Heart Failure|July 23, 2022
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trialMarco Metra, Ewa A Jankowska, Matteo Pagnesi, et al.
Biomed Research International|July 12, 2018
Ethical Use and Impact of Participatory Approaches to Research in Post-Disaster Environments: An Australian Bushfire Case StudyL Gibbs, K Block, C MacDougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2012
Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISAHilde P E Peters, Adam Rumjon, Sukhvinder S Bansal, et al.
Cardiovascular Diabetology|August 17, 2023
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trialGiuseppe Rosano, Piotr Ponikowski, Cristiana Vitale, et al.
American Journal of Hematology|June 15, 2017
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and managementMaria Domenica Cappellini, Josep Comin-Colet, Angel de Francisco, et al.
Genome Medicine|May 9, 2025
Early-life and concurrent predictors of the healthy adolescent microbiome in a cohort studyHannah E Laue, Amy D Willis, Fang Wang, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
Kidney International Reports|August 15, 2022
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients TrialPeter C Thomson, Patrick B Mark, Michele Robertson, et al.
Pageof 38

Showing results (331-340 of 373) with videos related to

Sort By:
Pageof 38
The New England Journal of Medicine|January 25, 2013
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysisIain C Macdougall, Robert Provenzano, Amit Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitorsGavin Whitehouse, Elizabeth Gray, Sotiris Mastoridis, et al.
European Journal of Heart Failure|July 23, 2022
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trialMarco Metra, Ewa A Jankowska, Matteo Pagnesi, et al.
Biomed Research International|July 12, 2018
Ethical Use and Impact of Participatory Approaches to Research in Post-Disaster Environments: An Australian Bushfire Case StudyL Gibbs, K Block, C MacDougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2012
Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISAHilde P E Peters, Adam Rumjon, Sukhvinder S Bansal, et al.
Cardiovascular Diabetology|August 17, 2023
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trialGiuseppe Rosano, Piotr Ponikowski, Cristiana Vitale, et al.
American Journal of Hematology|June 15, 2017
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and managementMaria Domenica Cappellini, Josep Comin-Colet, Angel de Francisco, et al.
Genome Medicine|May 9, 2025
Early-life and concurrent predictors of the healthy adolescent microbiome in a cohort studyHannah E Laue, Amy D Willis, Fang Wang, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
Kidney International Reports|August 15, 2022
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients TrialPeter C Thomson, Patrick B Mark, Michele Robertson, et al.
Pageof 38